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Background: We evaluated the safety and validity of cholecystomucoclasis (CM) and compared its intraoperative
characteristics with those of standard cholecystectomy (SC).
Methods: We enrolled 174 patients who underwent cholecystectomy and retrospectively evaluated the outcomes
of patients in the SC and CM groups.
Results: Significant differences in age (71.1 vs. 61.9 years), American Society of Anesthesiologists physical status
(ASA-PS), and serum C-reactive protein levels (CRP) (18.1 vs. 4.7 mg/dL) were observed between the CM and SC
groups. Conversely, no significant differences were observed in the operation time (129 vs. 108 min), amount of
blood loss (147 vs. 80 mL), intraoperative complications (0% vs. 5.7%), or duration of hospital stay (13.2 vs. 8.9 days)
between the 2 groups. A high conversion rate (35.3%), postoperative complications (33%), and frequent drain
insertions (94%) were observed in the CM group.
Conclusions: CM is a safe and valid surgical procedure and surgeons should not hesitate to transition to CM for
patients who are of advanced age, in poor general condition (high ASA classification), or have high levels of serum
CRP.
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Cholecystectomy, particularly laparoscopic cholecystec-
tomy (LC), has become the standard treatment for
patients with benign gallbladder disease [1-3]. Although
the indications for surgery in patients with acute chole-
cystitis have been expanding [4-6], there are cases where
standard cholecystectomy (SC) is difficult owing to the
presence of acute or chronic inflammation, strong
omental adhesion, or gangrenous cholecystitis. As
patients with benign gallbladder disease tend to be of
advanced age, safer and more feasible surgical techni-
ques are required for difficult cases [7-9].
Cholecystomucoclasis (CM) is a traditional method
that is combined with subtotal cholecystectomy and
involves the cauterization of the posterior gallbladder
wall preserved in the liver bed that remains after* Correspondence: tkd_tmy@nifty.com
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reproduction in any medium, provided the oranterior wall resection, in patients with advanced inflam-
matory cholecystitis [10]. CM, also called deroofing of
the gallbladder [11,12], is a useful procedure that
includes partial [13] or subtotal cholecystectomy [14,15].
Recently, increased experience in laparoscopic surgery
and other advanced techniques have shown that CM is a
safe and feasible option [16-21]. However, preoperative
conditions and intraoperative technical characteristics
have been less well described. Hence, we revaluated the
safety and validity of CM and compared its intraopera-
tive characteristics with those of SC.
Methods
Patients
As shown in Table 1, 174 patients (93 men and 81
women) underwent cholecystectomy at the Department
of Surgery, Asanogawa General Hospital, Kanazawa,
Japan, between January 2007 and December 2011, ex-
cluding those who were diagnosed with malignancy and
underwent choledocholithotomy or simultaneous resec-
tion of other organs.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.














Cholecystomucoclasis (deroofing) 18 (10.3)
Laparoscopic cholecystectomy (conventional) 163 (93.7)
SILC 18 (10.3)
Open cholecystectomy 11 (6.3)
Conversion (laparoscopic to open) 13 (7.5)
ASA-PS: American Society of Anesthesiologists physical status.
SILC: Single-incision laparoscopic cholecystectomy.
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(range, 23–95 years). Preoperative clinical diagnoses of
cholecystitis were made on the basis of each patient’s
history of right upper abdominal pain and tenderness,
fever, leukocytosis, increased C-reactive protein (CRP)
levels, and positive signs on computed tomography or
ultrasonography (thickened gallbladder wall and peri-
cholecystic fluid collection). All resected specimens were
also evaluated histopathologically. This study was approved
by the Institutional Review Board of the Asanogawa
General Hospital (AGH-IRB No. 22).
Operative technique
LC was performed by the standard 3 or 4-trocar tech-
nique. Briefly, the anesthetized patient was placed in the
standard supine, crucifix, reverse-Trendelenburg pos-
ition, with the surgeon on the patient’s left side. Pneu-
moperitoneum was achieved by visually guided, cannular
CO2 insufflation. The dissection was started at the
Calot’s triangle, and the cystic duct, the common bile
duct, and the cystic artery were exposed and divided be-
tween clips. Intraoperative cholangiography was rou-
tinely performed to detect residual calculus and bile
duct injury. The gallbladder itself was carefully mobi-
lized from the liver bed using electrocautery. An endo-
bag was always used to remove the gallbladder, thus
preventing wound infection. The abdominal cavity was
irrigated before the trocars were removed, and the fascial
defects were closed.In April 2010, single-incision laparoscopic cholecyst-
ectomy (SILC) was instituted at our institution and
subsequent LCs were performed using this technique.
For the SILC technique, the patient was positioned su-
pine on the operating table with the legs widely sepa-
rated. The surgeon stood between the patient’s legs,
and the cameraperson stood to the right of the surgeon
(near the patient’s left leg) [22]. A 2-cm vertical trans-
umbilical incision was made, and either a SILS port
(Covidien Inc., Norwalk, CT, USA) or the hand-made
glove method was used [23]. A 5-mm flexible endo-
scope (Olympus, Tokyo, Japan) was used for intra-
abdominal visualization. Cholecystectomy was then
performed as mentioned above and as described previ-
ously [24,25].
Open cholecystectomy (OC) was performed through a
right subcostal or a midline incision. In almost all cases,
decompression of the gallbladder was performed using
needle aspiration. Dissection was performed to identify
the cystic duct and the common bile duct. In cases of
advanced local inflammation, the dissection was per-
formed from the fundus towards Calot’s triangle. Intrao-
perative cholangiography was routinely performed.
Finally, the gallbladder was removed from the liver bed.
In principle, the gallbladder should be totally resected.
However, CM was considered, at the discretion of the
surgeon, to prevent massive bleeding or bile duct injury.
In particular, CM was applied in cases of a thinned nec-
rotic gallbladder wall due to advanced inflammation, a
thickened sclerotic gallbladder wall because of advanced
inflammation, the inability to determine the exact orien-
tation of the Calot’s triangle, and the burial of the gall-
bladder deep within the liver bed. In severe, gangrenous
cholecystitis, the dissection began from the fundus to
the neck of the gallbladder, after decompression of the
gallbladder. The residual gallbladder mucosa was cauter-
ized by electrocautery or argon plasma coagulation. If
the gallbladder wall was accidentally damaged, the gall-
bladder was continuously dissected from the orifice
(Figure 1, 2).
Data collection
The data were retrospectively collected from medical
records, operative reports, and histopathological reports.
The outcomes for the SC and CM groups were evalu-
ated. The outcome measures included the conversion
rate (laparoscopic to open), operation time, loss of blood
(low bleeding was defined as 0 mL), maximum preopera-
tive CRP level, American Society of Anesthesiologists
physical status (ASA-PS) score, success rate of intrao-
perative cholangiography, treatment of the proximal bile
duct stump, intraoperative complications, postoperative
complications, presence or absence of a drain, and
length of hospital stay.
Figure 1 Representative intraoperative findings of cholecystomucoclasis for acute cholecystitis. a: Overview of acute cholecystitis. b:
Double-clipped cystic artery (arrowhead). c: The gallbladder was incised carefully because of the lack of a clear indication of the correct layer. d:
The gallbladder mucosa cauterized by electrocautery (arrowhead).
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The values were expressed as means ± standard devia-
tions (SD). The statistical analysis was conducted using
the 2-sided Student’s t test and the Mann–Whitney U
test for continuous data or Fisher’s exact test and the
chi-squared test for categorical data. All statistical ana-
lyses were performed using the SPSS 10.0 softwarea
c
Figure 2 Representative intraoperative findings of cholecystomucocla
chronic cholecystitis. b: Injury of the gallbladder body wall while dissecting
exposed (arrowhead). c: The gallbladder was incised consecutively from the
removal showing the residual gallbladder posterior wall (arrowhead).package (SPSS, Chicago, IL, USA). Significance was
defined as P < 0.05.
Results
Patient characteristics and preoperative findings
The 174 patients who underwent cholecystectomy were
divided into the CM and SC groups. Data from the 2b
d
sis for atrophic cholecystitis. a: Overview of atrophic gallbladder in
from the liver bed. The gallbladder mucosa and gallstones were
site of the exposed gallbladder mucosa. d: Overview after gallbladder
Table 3 Operative findings
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laparoscopic approach was used for 17 patients, but SILC
was not applied. There was no difference in the sex ratio
of the 2 groups (P= 0.491). Patients in the CM group
were, on average, almost 10 years older than those in the
SC group (P= 0.006). The preoperative general condition
was assessed according to the ASA-PS score. The CM
group tended to include patients with scores indicating
greater severity (P= 0.038), and all patients with life-
threatening indications (classified as grade 4) underwent
SC. Preoperative laboratory data showed a significant dif-
ference in CRP levels between the CM and SC groups
(18.1 ± 10.5 mg/dL vs. 4.7 ± 8.1 mg/dL, P < 0.001).
Operative findings
The mean operation time was 129 min (range,
63–190 min) for the CM group and 108 min (range,
50–375 min) for the SC group (P= 0.084). The extent of
bleeding was not significantly different between the 2
groups (P= 0.247). Intraoperative cholangiography was
routinely attempted in all cases. The success rate for
intraoperative cholangiography was significantly lower in
the CM group (50% [9/18]) than in the SC group (92.9%
[145/156], P < 0.001). When the anatomy of the Calot’s
triangle was unclear or inflammation in the gallbladder
neck was advanced, the bile duct stump was treated at
the neck and the cholecystectomy was limited to aTable 2 Characterization of the cholecystomucoclasis and
standard cholecystectomy groups, preoperative findings,
and conversion rates













Mean CRP in mg/dL 18.1±10.5 4.7±8.1 <0.001
Range CRP in mg/dL 0.41–36.20 0.02–34.04
Approach to laparotomy
LC (conventional) 17 128
SILC 0 18
OC 1 10
CRP: C-reactive protein, LC: Laparoscopic cholecystectomy, SILC: Single-incision
laparoscopic cholecystectomy, OC: Open cholecystectomy.partial resection. The site of the proximal bile duct
stump was examined in the 2 groups. The number of
patients treated at the neck of gallbladder was signifi-
cantly more in the CM group than in the SC group
(P < 0.001). The treatment of the stump of the proximal
bile duct was also investigated; a clip was used for al-
most all patients of the SC group (84.0% [131/156]),
whereas various methods (e.g., endoloop, ligation, su-
ture, and elastic yarn) were used for patients in the CM
group. In the CM group, the stump could not be closed
in 2 patients; thus, only drainage was applied.
Conversion from LC to open cholecystectomy (OC)
was usually implemented to prevent bile duct injury
within 30 min of beginning the laparoscopy. In some
cases (e.g., massive bleeding from the liver bed or identi-
fication of bile duct injury after intraoperative cholangi-
ography), OC was used to repair the damage. The
conversion rate was significantly higher in the CM group
(35.3% [6/17]) than in the SC group (4.8% [7/146],
P < 0.001) (Table 3).
Complications and adequacy
The intraoperative and postoperative complications are
described in Table 4. Although the 2 groups did not dif-
fer significantly in this regard (P= 0.578), the CM groupCM SC P value
(n=18) (n=156)
Operation time (min)
Mean 129±34 108±48 0.084
Range 63–190 50–375
Amount of bleeding (mL)
Mean 146.7±185.2 79.7±236.4 0.247
Range 0–675 0–1970
Success rate of <0.001
intraoperative cholangiography
Possible 9 145
Not possible 9 11
Site of proximal bile duct stump <0.001
Cystic duct 11 148
Neck of gallbladder 7 8
Methodology of treatment
for bile duct stump




Elastic yarn (for transcystic drainage) 2 10
None 2 0
Conversion rate (%) 6/17(35.3) 7/146(4.8) <0.001
CM: Cholecystomucoclasis, SC: Standard cholecystectomy.
Table 4 Complications, reoperations, additional
treatments, drains, and lengths of hospital stay




Massive bleeding (>1000 mL) 0 3
Bile duct injury 0 6
Postoperative complications 0.001
Total 6 10
Major intra-abdominal bleeding 0 2
Bile leakage 2 4
Wound infection 3 2
Bacteremia (catheter infection) 0 1
Retained calculus 1 1
Reoperation 0 3 0.839
Major intra-abdominal bleeding 0 1
Bile leakage 0 2




Hospital stay (days) 0.495
Mean 13.2±6.4 8.9±26.1
Range 5–27 3–330
CM: Cholecystomucoclasis, SC: Standard cholecystectomy, EBD: Endoscopic
biliary drainage, PTCD: Percutaneous transhepatic cholangial drainage.
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group had a relatively high incidence of complications
(Figure 3). Three cases of massive bleeding (>1000 mL)












Figure 3 Detailed analysis of the severe intraoperative complicationsPostoperative complications were observed in 4
patients of the CM group. Bile leakage and wound infec-
tion occurred in 2 patients and a residual calculus,
which was subsequently removed endoscopically, was
observed in 1 patient. Additional surgical treatment was
not required for any of the CM patients. In the SC
group, postoperative complications were observed in 10
patients. Two patients experienced intra-abdominal
hemorrhage: 1 patient required reoperation and the
other was treated conservatively with blood transfusions.
Bile leakage was observed in 4 patients: 1 was treated
conservatively, 1 needed endoscopic drainage, 1 required
immediate reoperation, and 1 required reoperation even
though endoscopic drainage and percutaneous transhe-
patic cholangial drainage were both attempted.
A drain was inserted into the liver bed in almost all
CM patients (17/18), but only in some of the SC patients
(61/156, P < 0.001). The average length of the hospital
stay was 13.2 ± 6.4 days (range, 5–27 days) in the CM
group and 8.9 ± 26.1 days (range, 3–330 days) in the SC
group (P= 0.495).
Histopathological examination was performed for all
patients, with gallbladder cancer being diagnosed in 2
patients, who received additional treatment. No mortal-
ity was associated with the procedures in either group.
Discussion
Difficulties in performing cholecystectomy include a lack
of clarity of the anatomical orientation of the Calot’s tri-
angle, resulting from severe, acute inflammation or
chronic atrophic sclerotic change. In this situation, sub-
total cholecystectomy is recommended for a safe sur-
gery. Subtotal cholecystectomy can be performed using
2 methods: dissecting the neck of the gallbladder rather
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gallbladder to prevent bleeding from the liver bed. In the
latter method, ablation of the remaining mucosa is com-
mon and is referred to as CM.
In principle, the gallbladder should be completely
resected, as gallbladder carcinoma has been reported in
0.3–1.5% of patients who have undergone cholecystec-
tomy [26,27]; therefore, it is necessary to check for any
signs of malignancy during preoperative diagnostic im-
aging. Because CM or subtotal cholecystectomy may re-
sult in an intraoperative bile leak into the abdominal
cavity, these procedures are associated with potential
dissemination. Although there are no reports of residual
gallbladder cancer following CM or subtotal cholecystec-
tomy, Shimizu et al. reported a case of biliary tract can-
cer in the liver bed after subtotal cholecystectomy. They
considered the possibility of a peripheral type of intrahe-
patic cholangiocarcinoma as well as carcinomas from
the residual gallbladder mucosa or the Luschka duct
[28]. Therefore, regular follow-ups with diagnostic im-
aging are needed, even when the patient does not show
pathological evidence of malignancy.
The frequency of postoperative complications in sub-
total cholecystectomies has been reported to be 6.7–
20.7% [17-21], with the patients having an average age of
53–62.9 years. In the current study, a relatively high in-
cidence of postoperative complications (33% [6/18]) was
observed, and the average age of patients in the CM
group was 71.1 ± 8.4 years. In particular, 2 patients were
found to have postoperative bile leakage, both of whom
were treated with drainage only, without processing of
the bile duct stump. One patient required endoscopic
biliary drainage (EBD) and the other recovered spontan-
eously without any additional treatment. The reason for
the spontaneous closure was presumed to be the result
of postoperative firm adhesion and scar formation,
which is expected in patients with advanced inflamma-
tion. The SC group had 4 patients with postoperative
bile leakage. Two patients required a reoperation for bile
leakage closure, and the other 2 were treated by diver-
sion of bile from the leakage site by EBD or percutan-
eous transhepatic cholangial drainage. There were no
significant differences between the two groups in add-
itional treatment (P= 0.06), but the treatment for bile
leakage in SC group was more difficult.
Few detailed studies have reported on intraoperative
findings in these types of cholecystectomies. In the CM
group, there was no evidence of intraoperative damage
to the biliary tract, a finding that was similar in the SC
group. Additionally, there was no significant difference
in the amount of bleeding between the 2 groups, and
the CM group did not include patients exhibiting
massive bleeding (>1000 mL). During cholecystectomy,
bleeding primarily originates from the cystic arteries andthe liver bed; CM and subtotal cholecystectomy help
prevent bleeding from these important locations.
The conversion rate to OC was 35.3% in the CM
group, which was higher than that in previous reports
(1.7–7.7%) [18.19.21]. Thus, we emphasize on safety in
our surgical procedures and convert to OC without hesi-
tation in difficult cases. The lack of intraoperative com-
plications in the CM group is probably the result of
these efforts. Furthermore, patients who needed reopera-
tion were observed only in the SC group, highlighting
the need for a flexible approach according to patient
characteristics rather than adherence to a particular
policy of laparoscopic surgery in order to avoid unneces-
sary intraoperative complications and conversion to
laparotomy.
OCs are typically more closely associated with
advanced age, poor general condition, or a high inflam-
matory response than are laparoscopic surgeries [29].
These same characteristics are also associated with an
increased severity of acute cholecystitis, which may re-
sult in a more difficult surgery. The aforementioned pa-
tient characteristics are collective, but not independent,
risk factors for postoperative complications of acute gan-
grenous cholecystitis [30,31]. In addition, Schäfer et al.
have reported that advanced age and a high serum CRP
level may be predictive factors for the surgical proce-
dures that are used in patients undergoing laparotomy
and patients who were converted to laparotomy [32].
The current study was a retrospective study, with a se-
lection bias based on intraoperative findings; the CM
group showed an advanced age and a high serum CRP
level. With the transition to CM and open surgery in
mind, the conversion to a safe surgical procedure should
be considered in elderly patients with high inflammation
of the gallbladder neck.
Conclusions
The intraoperative technical characteristics of SC and
CM were analyzed, and a low rate of handling of the
cystic duct stump and a low success rate for intraopera-
tive cholangiography were observed in the CM group.
However, no significant differences were observed in the
operative time, amount of bleeding, and number of
intraoperative complications. Compared with SC, high
conversion rates and drain insertion rates were noted in
patients undergoing CM, but the length of hospital stay
did not differ significantly. CM is thus considered to be
a safe and valid surgical procedure. In addition, surgeons
should not hesitate to transition to CM for patients with
advanced age, poor general condition (high ASA classifi-
cation), and a high serum CRP level.
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